Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single‐center case series
Abstract Background Immune checkpoint inhibitors can result in overlap syndrome comprised of myasthenia gravis, myositis and myocarditis. However, the mortality predictors have not been clearly delineated. Methods We examined the characteristics of 11 patients diagnosed with overlap syndrome at Clev...
Saved in:
| Main Authors: | Joshua Longinow, Mohammad Zmaili, Warren Skoza, Nicholas Kondoleon, Robert Marquardt, Cassandra Calabrese, Pauline Funchain, Rohit Moudgil |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-02-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.5050 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of immune-related myocarditis, myositis and myasthenia gravis (MMM) overlap syndrome: a single institution case series and literature review
by: Alberto Sánchez-Camacho, et al.
Published: (2025-05-01) -
Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors
by: Abdulrahman Alghabban, MD, et al.
Published: (2025-05-01) -
Efgartigimod therapy for immune checkpoint inhibitor–associated myasthenia gravis with myositis: a case report
by: Feiteng Qi, et al.
Published: (2025-07-01) -
Overlap of myasthenia gravis, myocarditis, and inflammatory myopathy secondary to immune checkpoint inhibitor (pembrolizumab) on a background of previously undiagnosed thymoma-associated acetylcholine receptor antibody-positive myasthenia gravis
by: O. V. Finleyson
Published: (2025-04-01) -
Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report
by: Peng Zhong, et al.
Published: (2023-03-01)